Medicines Development & Delivery

BiologIC Technologies is developing the first world's biocomputer leveraging foundational IP and the latest 3D printing technologies.

Visit company site

Richard Vellacott

CEO

Using an innovative platform technology called PODS, Cell Guidance Systems can stabilize and sustainably release proteins for a variety of applications.

Visit company site

Michael Jones

Founder & CEO

A specialist biotech company focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices.

Visit company site

Dr Alvaro Goyanes

CEO

LightOx has developed a new light activated chemotherapy drug for the treatment and prevention of early-stage oral cancers and is current taking this drug into clinical trials.

Visit company site

Dr Sam Whitehouse

CEO

Medherant develops patches for transdermal drug delivery using a novel, proprietary, solvent-free adhesive technology.

Visit company site

Nigel Davis

Chief Business Officer

Offering a flexible manufacturing platform that closes, automates and standardizes cell and gene therapy manufacturing.

Visit company site

Jason Foster

CEO

A regenerative medicine company, pioneering synthetic nanoclays as a delivery platform for safe and precise tissue regeneration.

Visit company site

Agnieszka Janeczek

CEO

Supporting RNA delivery through its proprietary Bio-Courier® technology with the hybridization of organic materials with inorganic bioabsorbable silicon.

Visit company site